Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China
· Delayed Price · Currency is CNY 33.12
+0.31 (0.94%)
Mar 10, 2026, 10:14 AM CST
SHA:688076 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 10,370 | 11,915 | 11,411 | 9,583 | 4,890 | 8,811 | Upgrade
|
| Market Cap Growth | -5.24% | 4.42% | 19.08% | 95.95% | -44.50% | - | Upgrade
|
| Enterprise Value | 11,897 | 13,443 | 12,107 | 9,772 | 4,726 | 8,238 | Upgrade
|
| Last Close Price | 32.81 | 37.70 | 36.56 | 31.40 | 15.94 | 28.55 | Upgrade
|
| PE Ratio | 31.55 | 36.44 | 28.22 | 58.81 | 37.88 | 76.36 | Upgrade
|
| Forward PE | 16.16 | 17.44 | 20.25 | 50.65 | 31.86 | 30.20 | Upgrade
|
| PS Ratio | 5.34 | 6.13 | 7.02 | 9.27 | 7.51 | 13.68 | Upgrade
|
| PB Ratio | 3.31 | 3.80 | 4.25 | 4.38 | 2.54 | 4.87 | Upgrade
|
| P/TBV Ratio | 3.73 | 4.29 | 4.76 | 5.04 | 2.95 | 5.64 | Upgrade
|
| P/OCF Ratio | - | - | 28.52 | 27.36 | 166.95 | 48.75 | Upgrade
|
| EV/Sales Ratio | 6.12 | 6.92 | 7.45 | 9.46 | 7.26 | 12.79 | Upgrade
|
| EV/EBITDA Ratio | 19.77 | 22.33 | 18.27 | 30.27 | 27.72 | 41.45 | Upgrade
|
| EV/EBIT Ratio | 29.74 | 33.60 | 26.27 | 51.15 | 65.84 | 70.35 | Upgrade
|
| Debt / Equity Ratio | 0.82 | 0.82 | 0.61 | 0.41 | 0.17 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 4.29 | 4.29 | 2.45 | 2.74 | 1.86 | 0.41 | Upgrade
|
| Net Debt / Equity Ratio | 0.48 | 0.48 | 0.32 | 0.07 | -0.06 | -0.33 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.50 | 2.50 | 1.30 | 0.45 | -0.72 | -3.00 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -1.25 | -0.47 | 0.30 | 11.32 | Upgrade
|
| Asset Turnover | - | - | 0.38 | 0.34 | 0.28 | 0.37 | Upgrade
|
| Inventory Turnover | - | - | 1.20 | 1.27 | 1.07 | 1.41 | Upgrade
|
| Quick Ratio | - | - | 0.76 | 1.08 | 1.26 | 2.99 | Upgrade
|
| Current Ratio | - | - | 1.14 | 1.54 | 1.91 | 4.01 | Upgrade
|
| Return on Equity (ROE) | 11.24% | 11.24% | 16.41% | 8.04% | 6.58% | 7.84% | Upgrade
|
| Return on Assets (ROA) | - | - | 6.68% | 3.93% | 1.93% | 4.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.02% | 9.09% | 14.29% | 8.82% | 4.75% | 8.90% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 13.90% | 7.40% | 3.60% | 6.30% | Upgrade
|
| Earnings Yield | 3.15% | 2.74% | 3.54% | 1.70% | 2.64% | 1.31% | Upgrade
|
| FCF Yield | - | - | -6.05% | -3.24% | -8.37% | -0.60% | Upgrade
|
| Dividend Yield | 1.91% | - | 1.76% | 0.91% | 0.90% | 0.38% | Upgrade
|
| Payout Ratio | - | - | 29.37% | 35.36% | 31.43% | 5.24% | Upgrade
|
| Buyback Yield / Dilution | -2.19% | -2.19% | -2.52% | -1.28% | -10.06% | -19.95% | Upgrade
|
| Total Shareholder Return | -0.28% | -2.19% | -0.76% | -0.37% | -9.17% | -19.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.